<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Detection of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> at an early stage may significantly decrease mortality from the disease </plain></SENT>
<SENT sid="1" pm="."><plain>The current screening test of colonoscopy is of high efficacy, but its acceptance in the general public is rather low </plain></SENT>
<SENT sid="2" pm="."><plain>Availability of a blood- or stool-based test of DNA methylation markers is expected to improve the screening compliance for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> in the general population </plain></SENT>
<SENT sid="3" pm="."><plain>The goal of this review is to describe the recent advances in DNA methylation markers of stool and blood for early detection of <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, and envisage future developments toward their clinical availability </plain></SENT>
<SENT sid="4" pm="."><plain>More investigations should be performed to promote both basic and clinical research of DNA methylation markers in patients with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
</text></document>